WallStSmart
TRIB

Trinity Biotech plc

NASDAQ: TRIB · HEALTHCARE · MEDICAL DEVICES

$0.60
+0.00% today

Updated 2026-04-30

Market cap
$12.18M
P/E ratio
P/S ratio
0.25x
EPS (TTM)
$-1.60
Dividend yield
52W range
$1 – $2
Volume
0.2M

Trinity Biotech plc (TRIB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
-189.2%
Last 4 quarters
Revenue YoY growth
-10.1%
Most recent quarter
EPS YoY growth
+43.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+14.3%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+14.3%
2025-12-23
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-23$-0.40$0.89$1.02+14.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.00$-0.40$14.25M-6.0%
2025-03-31$-0.05$-1.24-2380.0%$7.58M-48.5%
2024-12-31$-0.30$-0.88-192.7%$15.86M+7.8%
2024-09-30$-0.40$-1.10-175.0%$15.15M+3.2%
2024-06-30$-0.65$-0.71-9.2%$15.84M+14.0%
2024-03-31$-0.12$-3.59-2890.7%$14.70M-0.8%
2023-12-31$-0.14$-0.18-25.0%$14.70M-18.5%
2023-09-30$-0.09$-0.15-66.7%$14.68M-18.6%
2023-06-30$-0.06$-0.15-150.0%$13.90M
2023-03-31$-0.06$-0.06+0.0%$14.83M
2022-12-31$-0.06$-0.27-350.0%$18.04M
2022-09-30$-0.04$-0.23-475.0%$18.04M

Frequently asked questions

Has Trinity Biotech plc beaten earnings estimates?
Trinity Biotech plc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports, with an average EPS surprise of -189.2% over the last 3 quarters.
How does TRIB stock react to earnings?
TRIB stock has moved an average of +14.3% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is Trinity Biotech plc's revenue growth rate?
Trinity Biotech plc reported year-over-year revenue growth of -10.1% in its most recent quarter, with EPS growing +43.7% year-over-year.